Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
about
Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsBuilding and re-building the heart by cardiomyocyte proliferationReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Direct Reprogramming-The Future of Cardiac Regeneration?Programming and reprogramming a human heart cellDirect cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicineMending broken hearts: cardiac development as a basis for adult heart regeneration and repairTranscription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogrammingMyeloid zinc finger 1 (Mzf1) differentially modulates murine cardiogenesis by interacting with an Nkx2.5 cardiac enhancerCardiac Progenitor Cells in Myocardial Infarction Wound Healing: A Critical ReviewInduced regeneration--the progress and promise of direct reprogramming for heart repair.Cardiac fibrosis in myocardial infarction-from repair and remodeling to regenerationTherapeutic Potential of Stem Cells Strategy for Cardiovascular DiseasesTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineGenetic engineering of somatic cells to study and improve cardiac functionGATA factors efficiently direct cardiac fate from embryonic stem cells.Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of successDirect reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogelsInduction of human cardiomyocyte-like cells from fibroblasts by defined factors.Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain.Matrix identity and tractional forces influence indirect cardiac reprogrammingHigh-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling.Generation of Functional Human Cardiac Progenitor Cells by High-Efficiency Protein Transduction.Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming.Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage.Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons.Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies.Reprogramming fibroblasts to endothelial cells: converted or born again?BAF60 A, B, and Cs of muscle determination and renewal.MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signaturesRegenerative medicine for the heart: perspectives on stem-cell therapy.Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogrammingHuman stem cells for modeling heart disease and for drug discovery.Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.Reprogramming for cardiac regeneration.Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5Integrative Analysis of the Developing Postnatal Mouse Heart Transcriptome.Contemporary perspective on endogenous myocardial regeneration.Transdifferentiation of Fibroblasts by Defined Factors.Induction of substantial myocardial regeneration by an active fraction of the Chinese herb Rosa laevigata Michx.
P2860
Q26750663-DD534FC3-F02A-47CE-A8AB-EBE94DAF84B4Q26765120-E91AAA9A-BA37-48CF-B8D1-0A1E651B6480Q26800082-49D8E175-647A-407F-9796-7D708C90438FQ26800909-6AE79F1B-AD2C-485E-BCEF-060E58A88B23Q26823933-F5E23514-5AEF-4879-ABAE-703965A3EEA3Q26824962-000CC227-F372-4A8D-960E-354515F3D409Q26852506-4DCCBEB0-0CB5-40FA-B79A-1931D0D12317Q27320356-D267E8B1-41DF-44AC-80B1-730488BF7B0FQ27323042-A1864CE1-41A7-4AE7-9C2B-E837D9A53229Q27686825-59EACFF4-C316-45C3-9830-2C4C7590A024Q27687630-29F1085A-AC41-4925-8C52-FD1618F394A2Q28068468-B9615D6E-D681-43DE-B5AB-4ACF340FA21FQ28068965-AA1E1714-670E-4DEF-BA37-4ECB9A4BE48EQ28076397-DB4B272F-36AC-446A-AF87-672BF990C9F2Q30416546-38B6627A-7F16-4151-8D48-E44B4E8DF5FCQ30538598-A3065025-08FD-4FD5-9442-9BD922E2E316Q30540551-956AC6F9-E1E3-410B-93A1-1EE5A525D965Q30541092-DAAFF854-0D75-4167-93F2-4F7C422B0BB8Q30542130-8DCFF05C-D9B2-4D57-AE89-882BB41B5EBEQ30545750-1AB8B262-C8E0-4890-9392-DB6AF6EF4DBBQ30559231-C0B61D31-7837-4E51-9037-F4089B1B0F85Q30665262-7E7B7670-38AD-4B65-A3B5-EED14D43CE24Q30687953-D22218FA-B585-4299-AE02-E0A27D56FC2BQ30724300-07F1206B-3232-4804-BC65-E371B49FB96DQ30834431-A05DACF0-7A23-494B-BFBE-9F7CB74DE1CBQ30842582-542F28EC-B792-477B-8D5D-EC36671C8AADQ34039059-AEAACE6F-AFD9-4787-AD70-37546D2891E3Q34276181-2DC2ED9D-68A4-4EE7-95C4-F26902530859Q34316322-FDB318D6-9763-4C0A-A28B-6B9C2B9F620CQ34343297-037339FE-28BE-439C-98FA-BE8B5BFF04D8Q34399774-5AC42E05-75EE-48B6-9474-A9A0A6EDCC97Q34408109-65E172D5-9AAA-475C-88AB-060FE2397C02Q34433363-B9018FB9-B46C-4230-AECC-B03E7E5CBE65Q34531894-1626C917-C137-47E5-8124-2D3272C2CD42Q35156623-5139A304-E522-4013-B394-3B3CE5331A44Q35654315-3A8EDD6D-CF99-43CD-9528-55128C8F79A3Q35705049-AD4475E1-46D1-4E43-9ADA-3659A1C559E0Q35774278-6161FB79-C9E9-4B35-B305-9BA214890B0AQ35805656-94980070-3F79-4C5C-88A8-045A1A9B2CA1Q35807259-695AC569-8774-4FA1-B6C0-9A8F164B1283
P2860
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@ast
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@en
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@nl
type
label
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@ast
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@en
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@nl
prefLabel
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@ast
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@en
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@nl
P2093
P2860
P1433
P1476
Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5
@en
P2093
David Milan
Jenny X Chen
Kuppusamy Rajarajan
Marc C Engels
Marcus-Andre Deutsch
Markus Krane
Moshe Rav-Acha
Ravi Karra
P2860
P356
10.1161/CIRCRESAHA.112.270264
P50
P577
2012-05-10T00:00:00Z